---
document_datetime: 2025-05-13 16:29:11
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kanjinti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: kanjinti-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 16.4439655
conversion_datetime: 2025-12-23 05:22:09.161777
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## KANJINTI

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,please alsorefertoEPAR-Proceduralstepstakenandscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| VariationtypeIA/    | This was an application for a group of | 13/05/2025                          |                                          | Annex II                        |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(Package Leaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000268786                     | variations. A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesforanactive substance,intermediate orfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*- Accepted A.ADMINISTRATIVE CHANGES-A.7 Deletionofmanufacturingsitesforanactive substance,intermediateorfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient (when mentioned in the   |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000258117 | B.I.a.1 Change in themanufacturer of a starting material/reagent/intermediate used in themanufacturingprocessof the active substanceorchangeinthemanufacturer (including where relevant quality control testing sites)of the active substance,where noPh.Eur.Certificate ofSuitability ispart of the approved dossier - B.I.a.1.f Changes to quality control testing arrangements for the active substance-replacement or addition of a site where batch control/testing takes place - Accepted                                                                                                                       | 25/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>